| The moolah
Silicon Valley-based Solace Health closed a $130 million Series C funding round that took its valuation to more than $1 billion. The round, led by IVP, brought Solace's overall fundraising total to $211 million since its founding in 2021. Other investors participating in the round included Menlo Ventures, SignalFire, Torch Capital, Inspired Capital and RiverPark Ventures. The platform
The goal behind Solace is simple: to connect more people to healthcare advocates. The startup offers a platform — covered by Medicare and most Medicare Advantage plans — that connects patients with advocates. These advocates help with tasks like scheduling appointments, finding in-network providers, understanding insurance coverage and bills, and coordinating care across multiple clinicians. Advocates work with patients through text, phone calls or video visits embedded directly in the platform. Solace works with patients facing everything from basic access issues — like finding available primary care doctors or specialists — to far more complex situations involving chronic illness, medication access and high-stakes treatment decisions. 'No homework' approach
Solace's advocates actually handle much of the work on a patient's behalf, rather than simply telling patients what steps to take next. CEO Jeremy Gurewitz described this as a "no homework" ethos — a deliberate departure from navigation services that overwhelm users with to-do lists. While plenty of care navigation companies exist, such as Transcarent and Quantum Health, he argued that acting directly for patients might be the only way to make progress in a system that is already exhausting to navigate. Eyeing an exit
The company is targeting 2028 for a potential IPO as it looks to continue expanding its reach, Gurewitz said. — By Katie Adams | 
No comments